Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: Salt
UNII: 55F75LJQ0V
Parent Compound: ANAMORELIN

Structure

InChI Key VFYAEUWJFGTGGO-GHTUPXNNSA-N
Smile CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1.Cl
InChI
InChI=1S/C31H42N6O3.ClH/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22;/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39);1H/t26-,31-;/m1./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C31H43ClN6O3
Molecular Weight 583.18
AlogP 2.72
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 9.0
Polar Surface Area 114.77
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 40.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Ghrelin receptor agonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Cachexia 2 D002100 ClinicalTrials
Fatigue 2 D005221 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials

Related Entries

Parent

Cross References

Resources Reference
ChEMBL CHEMBL2103794
EPA CompTox DTXSID70235443
FDA SRS 55F75LJQ0V
PubChem 16072155
SureChEMBL SCHEMBL4535148